Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Incidence of Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
7 evidence topics · 5 sources
Estimated U.S. new cases in 2026, all prostate cancer stages
| Measure | Quoted value |
|---|---|
| Estimated new cases of prostate cancer, United States, 2026 | “333,830”View highlighted excerpt for this quote |
U.S. incidence rate, all prostate cancer stages
Distant-stage disease at diagnosis, all prostate cancer
| SEER measure | Quoted value |
|---|---|
| Percentage of cases diagnosed at distant stage | “9%” |
U.S. incidence trend of regional-stage and distant-stage prostate cancer
“From 2014 through 2022, the prostate cancer incidence rate rose by 2.9% per year (Table 5), with a longer and steeper slope for regional‐stage (4.6% per year since 2013) and distant‐stage (5.6% per year since 2011) disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Modeled U.S. annual incidence of metastatic castration-resistant prostate cancer, 2009 and 2020
“The model estimated the prevalence of prostate cancer as 2,219,280 in the US in 2009 and 3,072,480 in 2020, and incidence of mCRPC as 36,100 and 42,970, respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The majority (86%) of incidence flow into mCRPC states was from the nmCRPC clinical state.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Newly diagnosed metastatic castration-resistant prostate cancer in Medicare fee-for-service, 2014 to 2019
“Men newly diagnosed with mCRPC were identified in Medicare fee-for-service claims during 1/1/2014–6/30/2019.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The final study population consisted of 14,780 men” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote